<DOC>
	<DOCNO>NCT01597284</DOCNO>
	<brief_summary>The investigator propose evaluate compliance oral cancer therapy , particularly possible link observance cognitive function patient initiation treatment . To knowledge , study among first conduct issue France innovative approach management cancer patient . The inclusion cognitive dysfunction part comprehensive approach improve quality life fully meet objective plan cancer , include axis `` Living cancer '' highlight Cancer Plan</brief_summary>
	<brief_title>Oral Therapies Oncology : Cognitive Function Compliance</brief_title>
	<detailed_description />
	<criteria>Age 18 year , Patients treat first prescription exclusive oral therapy ( chemotherapy and/or target therapy ) part cancer , Patients begin treatment ZYTIGA Â® ( abiraterone acetate ) incluables , Patients asymptomatic brain metastasis incluables , Lack personality disorder psychiatric illness scalable , Knowledge speak write French , Having sign inform consent study participation . Pathology psychiatric Refusal participate , Patient unable respond cognitive test , Documented use drug , Heavy drinking , Cancer primitive central nervous system , Participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Oral therapy</keyword>
	<keyword>Cancer</keyword>
	<keyword>cognitive function</keyword>
	<keyword>compliance</keyword>
</DOC>